| Primary |
| Anxiety |
31.7% |
| Product Used For Unknown Indication |
19.0% |
| Depression |
9.5% |
| Suicide Attempt |
9.5% |
| Post-traumatic Stress Disorder |
6.3% |
| Hypertension |
4.8% |
| Pain |
4.8% |
| Autism |
3.2% |
| Culture Positive |
3.2% |
| Anxiety Disorder |
1.6% |
| Atrial Fibrillation |
1.6% |
| Cerebrovascular Accident |
1.6% |
| Overdose |
1.6% |
| Panic Attack |
1.6% |
|
| Death |
8.0% |
| Depression |
8.0% |
| Restlessness |
8.0% |
| Ventricular Fibrillation |
8.0% |
| Vomiting |
8.0% |
| Clavicle Fracture |
4.0% |
| Convulsion |
4.0% |
| Dehydration |
4.0% |
| Dizziness |
4.0% |
| Drug Dependence |
4.0% |
| Drug Withdrawal Syndrome |
4.0% |
| Electrocardiogram Qt Prolonged |
4.0% |
| Facial Bones Fracture |
4.0% |
| Headache |
4.0% |
| Heart Rate Increased |
4.0% |
| Incorrect Route Of Drug Administration |
4.0% |
| Insomnia |
4.0% |
| Left Ventricular Hypertrophy |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Nightmare |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
41.1% |
| Anxiety |
14.3% |
| Drug Exposure During Pregnancy |
7.1% |
| Drug Use For Unknown Indication |
6.3% |
| Depression |
5.4% |
| Breast Cancer |
3.6% |
| Hypertension |
2.7% |
| Pain |
2.7% |
| Agitation |
1.8% |
| Antidepressant Therapy |
1.8% |
| Dementia |
1.8% |
| Hyperthyroidism |
1.8% |
| Inflammation |
1.8% |
| Insomnia |
1.8% |
| Oedema |
1.8% |
| Asthma |
0.9% |
| Bipolar Disorder |
0.9% |
| Bladder Disorder |
0.9% |
| Bronchitis Chronic |
0.9% |
| Chest Pain |
0.9% |
|
| Overdose |
15.4% |
| Convulsion |
7.7% |
| Pyrexia |
7.7% |
| Ventricular Septal Defect |
7.7% |
| Haematochezia |
3.8% |
| Headache |
3.8% |
| Lethargy |
3.8% |
| Mental Status Changes |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Renal Failure Acute |
3.8% |
| Respiratory Arrest |
3.8% |
| Respiratory Tract Infection |
3.8% |
| Restlessness |
3.8% |
| Rhabdomyolysis |
3.8% |
| Somnolence |
3.8% |
| Suicide Attempt |
3.8% |
| Tachypnoea |
3.8% |
| Tardive Dyskinesia |
3.8% |
| Vision Blurred |
3.8% |
| Visual Impairment |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
12.9% |
| Anxiety |
9.8% |
| Depression |
7.2% |
| Hypertension |
5.7% |
| Pain |
4.6% |
| Crohn's Disease |
4.5% |
| Osteoporosis |
4.2% |
| Rheumatoid Arthritis |
4.0% |
| Insomnia |
2.0% |
| Contraception |
1.8% |
| Hypersensitivity |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Osteoarthritis |
1.7% |
| Prophylaxis |
1.7% |
| Arthritis |
1.5% |
| Hepatitis C |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Intraocular Pressure Increased |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
|
| Vomiting |
17.9% |
| Nausea |
9.0% |
| Pain |
7.7% |
| Myocardial Infarction |
6.4% |
| Drug Hypersensitivity |
5.1% |
| Somnolence |
5.1% |
| Swelling |
5.1% |
| Drug Ineffective |
3.8% |
| Headache |
3.8% |
| Pyrexia |
3.8% |
| Suicidal Ideation |
3.8% |
| Suicide Attempt |
3.8% |
| Syncope |
3.8% |
| Urinary Tract Infection |
3.8% |
| Venous Insufficiency |
3.8% |
| Acute Myocardial Infarction |
2.6% |
| Anxiety |
2.6% |
| Eructation |
2.6% |
| Fatigue |
2.6% |
| Injection Site Pain |
2.6% |
|
| Interacting |
| Anxiety |
33.3% |
| Atrial Fibrillation |
33.3% |
| Cerebrovascular Accident |
33.3% |
|
| Prothrombin Time Shortened |
100.0% |
|
